{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:58:29Z","timestamp":1785405509862,"version":"3.56.0"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>Bone metabolism-related disorders represent a significant global health burden, due to their high prevalence and substantial socioeconomic costs, particularly osteoporosis. Conventional antiresorptive and anabolic agents have well-established clinical utility, such as bisphosphonates, denosumab, teriparatide, and romosozumab. Nevertheless, their long-term clinical use remains limited by safety concerns and inadequate efficacy in a subset of patients. In this review, we highlight recent chemical innovations designed to mechanistically reprogram the skeletal microenvironment and overcome those longstanding barriers. We also analyze how the metabolic coupling signals govern bone bioenergetics, particularly within the Wnt and RANKL axes. We place specific focus on three emerging and transformative strategies: proteolysis-targeting chimeras (PROTACs), bone-targeted senolytics, and direct metabolic modulators. Ultimately, we provide a multidisciplinary roadmap for the development of next-generation therapeutics to achieve durable skeletal restoration in patients with bone metabolic disorders.<\/jats:p>","DOI":"10.3389\/fchem.2026.1861883","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:02:18Z","timestamp":1785402138000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond"],"prefix":"10.3389","volume":"14","author":[{"given":"Yeqiong","family":"Song","sequence":"first","affiliation":[{"name":"Endocrinology Department, Third People\u2019s Hospital of Hangzhou","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhejiang University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhenjiang Fourth Peoples Hospital and Zhenjiang Women and Children\u2019s Hospital","place":["Zhenjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkai","family":"Wang","sequence":"additional","affiliation":[{"name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyang","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhejiang University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Third People\u2019s Hospital of Hangzhou","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.devcel.2011.09.003","article-title":"Structural basis of Wnt signaling inhibition by dickkopf binding to LRP5\/6","volume":"21","author":"Ahn","year":"2011","journal-title":"Dev. Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"152230","DOI":"10.1016\/j.bbrc.2025.152230","article-title":"Schisandrin A induces osteoblast differentiation to treat glucocorticoid-induced osteoporosis through activating Wnt pathway","volume":"776","author":"Ai","year":"2025","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.20945\/2359-3997000000566","article-title":"Anabolic therapy for osteoporosis: update on efficacy and safety","volume":"66","author":"Bandeira","year":"2022","journal-title":"Archives Endocrinol. Metabolism"},{"key":"B5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1158\/0008-5472.can-16-2686","article-title":"MCT1 inhibitor AZD3965 increases mitochondrial metabolism, facilitating combination therapy and noninvasive magnetic resonance spectroscopy","volume":"77","author":"Beloueche-Babari","year":"2017","journal-title":"Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41413-024-00374-0","article-title":"Metabolic reprogramming in skeletal cell differentiation","volume":"12","author":"Bertels","year":"2024","journal-title":"Bone Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1039\/D1CB00011J","article-title":"Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation","volume":"2","author":"Bond","year":"2021","journal-title":"RSC Chem. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Archives Biochem. Biophysics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00223-004-0285-8","article-title":"Acidosis inhibits bone Formation by osteoblasts in vitro by preventing mineralization","volume":"77","author":"Brandao-Burch","year":"2005","journal-title":"Calcif. Tissue Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41413-018-0038-3","article-title":"NOTUM inhibition increases endocortical bone formation and bone strength","volume":"7","author":"Brommage","year":"2019","journal-title":"Bone Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41422-020-0314-9","article-title":"Elimination of senescent cells by \u03b2-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice","volume":"30","author":"Cai","year":"2020","journal-title":"Cell Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jare.2025.01.027","article-title":"Transcriptional regulation of Rankl by Txnip-Ecd in aging and diabetic related osteoporosis","volume":"77","author":"Cao","year":"2025","journal-title":"J. Adv. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"890693","DOI":"10.3389\/fphar.2022.890693","article-title":"Fisetin: an integrated approach to identify a strategy promoting osteogenesis","volume":"13","author":"Carbonare","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: the path to the clinic","volume":"28","author":"Chaib","year":"2022","journal-title":"Nat. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm.4010","article-title":"Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice","volume":"22","author":"Chang","year":"2015","journal-title":"Nat. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1096\/fj.201900201rr","article-title":"Increased glycolysis mediates Wnt7b-induced bone formation","volume":"33","author":"Chen","year":"2019","journal-title":"FASEB J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1101\/gad.17276711","article-title":"Control of the senescence-associated secretory phenotype by NF-\u03baB promotes senescence and enhances chemosensitivity","volume":"25","author":"Chien","year":"2011","journal-title":"Genes and Dev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrd.2017.116","article-title":"Senescent cells: an emerging target for diseases of ageing","volume":"16","author":"Childs","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"B23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/nejmoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00109-013-1084-3","article-title":"Function of matrix IGF-1 in coupling bone resorption and formation","volume":"92","author":"Crane","year":"2013","journal-title":"J. Mol. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-2966-5_18","article-title":"Role of TGF-\u03b2 signaling in coupling bone remodeling","volume":"1344","author":"Crane","year":"2015","journal-title":"Methods Molecular Biology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.chembiol.2017.05.024","article-title":"Targeted protein degradation: from chemical biology to drug discovery","volume":"24","author":"Cromm","year":"2017","journal-title":"Cell Chemical Biology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"69219","DOI":"10.18632\/oncotarget.18215","article-title":"Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt\u2019s lymphoma anti-tumor activity","volume":"8","author":"Curtis","year":"2017","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","first-page":"675385","DOI":"10.3389\/fendo.2021.675385","article-title":"The role of osteoclast energy metabolism in the occurrence and development of osteoporosis","volume":"12","author":"Da","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.joca.2019.05.006","article-title":"Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment","volume":"27","author":"Deshmukh","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"B31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1074\/jbc.m111.306472","article-title":"Evidence for irreversible inhibition of glycogen synthase Kinase-3\u03b2 by Tideglusib","volume":"287","author":"Dom\u00ednguez","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cmet.2013.03.017","article-title":"WNT-LRP5 signaling induces warburg effect through mTORC2 activation during osteoblast differentiation","volume":"17","author":"Esen","year":"2013","journal-title":"Cell Metab."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1136547\/v1","article-title":"Mechanical overload regulates osteoblast proliferation, differentiation and mineralization through Wnt\/\u0392-Catenin signaling pathway","author":"Fan","year":"2021","journal-title":"Res. Square"},{"key":"B34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2022","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","article-title":"Targeting cellular senescence prevents age-related bone loss in mice","volume":"23","author":"Farr","year":"2017","journal-title":"Nat. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1038\/s41591-024-03096-2","article-title":"Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial","volume":"30","author":"Farr","year":"2024","journal-title":"Nat. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/pr.119.018762","article-title":"Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease","volume":"72","author":"Felmlee","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","article-title":"Strategies for targeting senescent cells in human disease","volume":"1","author":"Gasek","year":"2021","journal-title":"Nat. Aging"},{"key":"B39","doi-asserted-by":"publisher","first-page":"33132","DOI":"10.1074\/jbc.m500608200","article-title":"Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression","volume":"280","author":"Gaur","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"8177","DOI":"10.1038\/s41467-023-44031-2","article-title":"Harnessing PROTAC technology to combat stress hormone receptor activation","volume":"14","author":"Gazorpak","year":"2023","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"111672","DOI":"10.1016\/j.cellsig.2025.111672","article-title":"\u03b2-Sitosterol inhibits osteoclast activity and reduces ovariectomy-induced bone loss by regulating the cAMP and NF-\u03baB signaling pathways","volume":"130","author":"Guo","year":"2025","journal-title":"Cell. Signal."},{"key":"B43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/cr.2011.127","article-title":"Small molecule-based disruption of the Axin\/\u03b2-catenin protein complex regulates mesenchymal stem cell differentiation","volume":"22","author":"Gwak","year":"2011","journal-title":"Cell Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family \u2013 structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/s41467-020-15838-0","article-title":"Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity","volume":"11","author":"He","year":"2020","journal-title":"Nat. Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41418-025-01587-4","article-title":"AARS1-mediated lactylation of H3K18 and STAT1 promotes ferroptosis in diabetic nephropathy","volume":"33","author":"Hong","year":"2025","journal-title":"Cell Death Differ."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1038\/s41467-022-33006-4","article-title":"Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1021\/acs.jmedchem.3c01414","article-title":"Discovery of novel potent and fast BTK PROTACs for the treatment of osteoclasts-related inflammatory diseases","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1126\/science.1222879","article-title":"Structural basis of Wnt Recognition by frizzled","volume":"337","author":"Janda","year":"2012","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature22306","article-title":"Surrogate Wnt agonists that phenocopy canonical Wnt and \u03b2-catenin signalling","volume":"545","author":"Janda","year":"2017","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1021\/acs.jmedchem.8b02027","article-title":"Development of small-molecules targeting receptor activator of nuclear Factor-\u03baB ligand (RANKL)\u2014Receptor activator of nuclear Factor-\u03baB (RANK) protein\u2013protein interaction by structure-based virtual screening and hit optimization","volume":"62","author":"Jiang","year":"2019","journal-title":"J. Med. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrd4233","article-title":"Can we safely target the WNT pathway?","volume":"13","author":"Kahn","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"B54","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature14259","article-title":"Notum deacylates Wnt proteins to suppress signalling activity","volume":"519","author":"Kakugawa","year":"2015","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41574-020-0335-y","article-title":"The role of cellular senescence in ageing and endocrine disease","volume":"16","author":"Khosla","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11914-022-00756-5","article-title":"Osteoclast recycling and the rebound phenomenon following denosumab discontinuation","volume":"20","author":"Kim","year":"2022","journal-title":"Curr. Osteoporos. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.11005\/jbm.2022.29.2.93","article-title":"Effect of denosumab on the change of osteoclast precursors compared to zoledronate treatment in postmenopausal women with osteoporosis","volume":"29","author":"Kong","year":"2022","journal-title":"J. Bone Metabolism"},{"key":"B58","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s11914-023-00793-8","article-title":"Advances in osteoporosis therapy: focus on osteoanabolic agents, secondary fracture prevention, and perioperative bone health","volume":"21","author":"Kostenuik","year":"2023","journal-title":"Curr. Osteoporos. Rep."},{"key":"B59","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd3705","article-title":"Bench to bedside: elucidation of the OPG\u2013RANK\u2013RANKL pathway and the development of denosumab","volume":"11","author":"Lacey","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/s0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/er.2017-00064","article-title":"Energy metabolism of the osteoblast: implications for osteoporosis","volume":"38","author":"Lee","year":"2017","journal-title":"Endocr. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"108108","DOI":"10.1016\/j.celrep.2020.108108","article-title":"Malic enzyme Couples Mitochondria with aerobic glycolysis in osteoblasts","volume":"32","author":"Lee","year":"2020","journal-title":"Cell Rep."},{"key":"B64","doi-asserted-by":"publisher","first-page":"19883","DOI":"10.1074\/jbc.m413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","article-title":"Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia","volume":"39","author":"Li","year":"2006","journal-title":"Bone"},{"key":"B66","doi-asserted-by":"publisher","first-page":"116456","DOI":"10.1016\/j.bone.2022.116456","article-title":"Pharmacological inhibition of DKK1 promotes spine fusion in an ovariectomized rat model","volume":"162","author":"Li","year":"2022","journal-title":"Bone"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41586-024-07992-y","article-title":"AARS1 and AARS2 sense l-lactate to regulate cGAS as global lysine lactyltransferases","volume":"634","author":"Li","year":"2024","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","first-page":"114840","DOI":"10.1016\/j.jconrel.2026.114840","article-title":"Cu2+-chelated epigallocatechin gallate nanoparticle-functionalized hydrogel promotes osteogenesis by inhibiting ferroptosis","volume":"394","author":"Li","year":"2026","journal-title":"J. Control. Release"},{"key":"B69","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.3791","article-title":"Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference\u2013based bone anabolic strategy","volume":"21","author":"Liang","year":"2015","journal-title":"Nat. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2147\/dddt.s127568","article-title":"Profile of romosozumab and its potential in the management of osteoporosis","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.4049\/jimmunol.0904033","article-title":"Structural and functional insights of RANKL\u2013RANK interaction and signaling","volume":"184","author":"Liu","year":"2010","journal-title":"J. Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3892\/ijmm.2015.2382","article-title":"\u03b2-catenin signaling induces the osteoblastogenic differentiation of human pre-osteoblastic and bone marrow stromal cells mainly through the upregulation of osterix expression","volume":"36","author":"Liu","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/cells11050831","article-title":"The osteocyte stimulated by Wnt Agonist SKL2001 is a safe osteogenic niche improving bioactivities in a polycaprolactone and cell integrated 3D module","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-74063-3","article-title":"Nanozyme-engineered liners for proactive prevention of wear particle-induced osteolysis","author":"Liu","year":"2026","journal-title":"Nat. Commun."},{"key":"B75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41422-023-00864-6","article-title":"Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation","volume":"34","author":"Mao","year":"2024","journal-title":"Cell Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/acel.12220","article-title":"SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass","volume":"13","author":"Mercken","year":"2014","journal-title":"Aging Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/nejm200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e12882","DOI":"10.1111\/cpr.12882","article-title":"Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling","volume":"53","author":"Ni","year":"2020","journal-title":"Cell Prolif."},{"key":"B79","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jphs.2023.09.005","article-title":"Lactate dehydrogenase A inhibition prevents RANKL-induced osteoclastogenesis by reducing enhanced glycolysis","volume":"153","author":"Nishioku","year":"2023","journal-title":"J. Pharmacol. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1038\/s41467-021-25453-2","article-title":"Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice","volume":"12","author":"Novais","year":"2021","journal-title":"Nat. Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbrc.2004.04.025","article-title":"Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis","volume":"318","author":"Ohnaka","year":"2004","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B82","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3389\/fphar.2017.00803","article-title":"Pharmacological therapy of osteoporosis: a systematic Current review of literature","volume":"8","author":"Pavone","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.drudis.2020.07.013","article-title":"Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective","volume":"25","author":"Pike","year":"2020","journal-title":"Drug Discov. Today"},{"key":"B84","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","article-title":"Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo","volume":"52","author":"Ring","year":"2003","journal-title":"Diabetes"},{"key":"B85","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.97760","article-title":"Introductory chapter: osteoporosis overview","volume-title":"IntechOpen eBooks, (IntechOpen)","author":"Rodrigo","year":"2021"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/nejmoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1\u2013Cullin\u2013F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1016\/j.bmc.2010.07.045","article-title":"Novel indolylmaleimide acts as GSK-3\u03b2 inhibitor in human neural progenitor cells","volume":"18","author":"Schm\u00f6le","year":"2010","journal-title":"Bioorg. and Med. Chem."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","article-title":"The rise of molecular glues","volume":"184","author":"Schreiber","year":"2021","journal-title":"Cell"},{"key":"B90","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd.2016.29","article-title":"Small molecules, big targets: drug discovery faces the protein\u2013protein interaction challenge","volume":"15","author":"Scott","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"B91","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fcell.2020.00354","article-title":"The senolytic drug navitoclax (ABT-263) causes trabecular bone loss and impaired osteoprogenitor function in aged mice","volume":"8","author":"Sharma","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/08982104.2025.2602599","article-title":"Development of icariin-loaded bone-targeting liposomes and its anti-osteoporosis effects and mechanism","volume":"36","author":"Sheng","year":"2025","journal-title":"J. Liposome Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fendo.2015.00041","article-title":"Coupling signals between the osteoclast and osteoblast: how are messages transmitted between these temporary visitors to the bone surface?","volume":"6","author":"Sims","year":"2015","journal-title":"Front. Endocrinol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1021\/acs.bioconjchem.9b00025","article-title":"Antibody delivery for intracellular targets: emergent therapeutic potential","volume":"30","author":"Singh","year":"2019","journal-title":"Bioconjugate Chem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/s2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the global Burden of Disease Study 2021","volume":"5","author":"Steinmetz","year":"2023","journal-title":"Lancet Rheumatology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"22141","DOI":"10.1021\/acsnano.5c03023","article-title":"Three-Dimensional bioprinted scaffolds loaded with multifunctional magnesium-based metal\u2013organic frameworks improve the senescence microenvironment prompting aged bone defect repair","volume":"19","author":"Sun","year":"2025","journal-title":"ACS Nano"},{"key":"B98","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1016\/j.joca.2024.02.311","article-title":"Radiographic and pain outcomes from a phase 3 extension Study (OA-07) evaluating the safety and efficacy of repeat lorecivivint injections over 3 years in subjects with severe knee osteoarthritis","volume":"32","author":"Swearingen","year":"2024","journal-title":"Osteoarthr. Cartil."},{"key":"B99","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1158\/1535-7163.mct-24-0744","article-title":"Inhibition of DKK-1 by WAY262611 inhibits Osteosarcoma metastasis","volume":"24","author":"Tal","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1093\/rheumatology\/keae610","article-title":"Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials","volume":"64","author":"Tambiah","year":"2025","journal-title":"Rheumatology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-\u03b21\u2013induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.addr.2007.09.007","article-title":"Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update","volume":"60","author":"Trevaskis","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.chembiol.2020.12.004","article-title":"Targeted degradation of the enhancer lysine acetyltransferases CBP and p300","volume":"28","author":"Vannam","year":"2021","journal-title":"Cell Chemical Biology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1517\/14712598.2013.833602","article-title":"Therapeutic antibodies to intracellular targets in cancer therapy","volume":"13","author":"Veomett","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00198-024-07036-1","article-title":"Secondary fracture prevention in primary care: a narrative review","volume":"35","author":"Wang","year":"2024","journal-title":"Osteoporos. Int."},{"key":"B106","doi-asserted-by":"publisher","first-page":"20708","DOI":"10.1021\/acs.jmedchem.4c02539","article-title":"Generation of BT-Amide, a bone-targeted Pyk2 inhibitor, effective via oral administration, for the prevention of glucocorticoid-induced bone loss","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"B107","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3892\/ijmm.2020.4470","article-title":"Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression","volume":"45","author":"Wei","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1038\/ncomms13176","article-title":"SIKs control osteocyte responses to parathyroid hormone","volume":"7","author":"Wein","year":"2016","journal-title":"Nat. Commun."},{"key":"B109","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/nejmcp1012926","article-title":"Glucocorticoid-Induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2796.2006.01695.x","article-title":"Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies","volume":"260","author":"Wiens","year":"2006","journal-title":"J. Intern. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12967-023-04563-z","article-title":"Romosozumab in osteoporosis: yesterday, today and tomorrow","volume":"21","author":"Wu","year":"2023","journal-title":"J. Transl. Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2301300","DOI":"10.1002\/advs.202301300","article-title":"Endothelial cell-derived lactate triggers bone mesenchymal stem cell histone lactylation to attenuate osteoporosis","volume":"10","author":"Wu","year":"2023","journal-title":"Adv. Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2384889","DOI":"10.1080\/08916934.2024.2384889","article-title":"LDHA-induced histone lactylation mediates the development of osteoarthritis through regulating the transcription activity of TPI1 gene","volume":"57","author":"Xia","year":"2024","journal-title":"Autoimmunity"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age","volume":"112","author":"Xu","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41392-023-01467-8","article-title":"Targeting strategies for bone diseases: signaling pathways and clinical studies","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B117","doi-asserted-by":"publisher","first-page":"11442","DOI":"10.1097\/js9.0000000000004934","article-title":"Lactylome-based investigation of osteoarthritic subchondral bone reveals cell-specific differential expression of histone H4K12 lactylation: an experimental study","volume":"112","author":"Xu","year":"2026","journal-title":"Int. J. Surg."},{"key":"B118","doi-asserted-by":"publisher","first-page":"10992","DOI":"10.1021\/acs.jmedchem.2c00081","article-title":"Development of an orally active small-molecule inhibitor of receptor activator of nuclear Factor-\u03baB ligand","volume":"65","author":"Yang","year":"2022","journal-title":"J. Med. Chem."},{"key":"B119","doi-asserted-by":"publisher","first-page":"9381","DOI":"10.1021\/acs.jmedchem.6b00938","article-title":"A bone-seeking trans-Cyclooctene for pretargeting and bioorthogonal chemistry: a proof of concept Study using 99mTc- and 177Lu-Labeled tetrazines","volume":"59","author":"Yazdani","year":"2016","journal-title":"J. Med. Chem."},{"key":"B120","doi-asserted-by":"publisher","first-page":"847","DOI":"10.55563\/clinexprheumatol\/gskbin","article-title":"A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients","volume":"43","author":"Yaz\u0131c\u0131","year":"","journal-title":"Clin. Exp. Rheumatology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"854","DOI":"10.55563\/clinexprheumatol\/hjt118","article-title":"A Phase 3, 56-week, randomised, double-blind, placebo-controlled study utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis: OA-11 Study","volume":"43","author":"Yaz\u0131c\u0131","year":"","journal-title":"Clin. Exp. Rheumatology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coph.2018.03.010","article-title":"Targeting therapeutics to bone by conjugation with bisphosphonates","volume":"40","author":"Young","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"19710","DOI":"10.1074\/jbc.RA118.004434","article-title":"Oligomerization of Frizzled and LRP5\/6 protein initiates intracellular signaling for the canonical WNT\/\u03b2-catenin pathway","volume":"293","author":"Yue","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B124","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B126","doi-asserted-by":"publisher","first-page":"eadk6084","DOI":"10.1126\/sciadv.adk6084","article-title":"Engineered MgO nanoparticles for cartilage-bone synergistic therapy","volume":"10","author":"Zheng","year":"2024","journal-title":"Sci. Adv."},{"key":"B127","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl\u20102 family of anti\u2010apoptotic factors","volume":"15","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"B128","doi-asserted-by":"publisher","first-page":"955","DOI":"10.18632\/aging.101202","article-title":"New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463","volume":"9","author":"Zhu","year":"2017","journal-title":"Aging"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","article-title":"Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis","volume":"187","author":"Zong","year":"2024","journal-title":"Cell"}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1861883\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:02:19Z","timestamp":1785402139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1861883\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":129,"alternative-id":["10.3389\/fchem.2026.1861883"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2026.1861883","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1861883"}}